TRENTON, NJ (November 13, 2015) — BioNJ, the trade association for New Jersey’s life sciences industry, announced that Randi Bromberg joined the organization as Vice President, Communications and Marketing. Randi brings more than 25 years of experience, including managing media relations and writing and executing forward-thinking marketing strategies and initiatives that foster member engagement, build awareness and drive growth. With a strong analytical and market research background, Randi has a keen eye for identifying and developing new marketing opportunities.
Most recently, Randi served as Executive Director of Marketing for ASI, the leading trade association within the advertising specialty industry. Randi’s broad range of experience includes business intelligence, branding, marketing communication, customer relationship management, social media, public relations and program development.
Randi began her career in medical and scientific publishing, where she spent more than 10 years building the marketing and communications programs for some of the most prestigious medical associations in the world.
“We are pleased to have someone of Randi’s caliber join the team,” said BioNJ President and CEO Debbie Hart. “In her role as Vice President, Communications and Marketing, Randi is supporting BioNJ’s mission to enhance the robust life sciences ecosystem in the State of New Jersey by creating and executing communications and marketing strategies and programs that will help our Members help their Patients.”
Randi can be reached at RBromberg@BioNJ.org or at 609-890-3185. For more information on BioNJ, please visit www.BioNJ.org.
BioNJ, The Gateway to Health, is a powerful network of 400 Member Investors representing research-based life sciences companies and stakeholders dedicated to propelling a vibrant ecosystem where Science is Supported, Companies are Created, Drugs are Developed and Patients are Paramount. Because Patients Can’t WaitSM, BioNJ is committed to the growth and prosperity of New Jersey’s life sciences ecosystem to help accelerate the discovery, development and commercialization of therapies and cures that save and improve lives and lessen the burden of illness and disease to society. As the industry’s voice in New Jersey, we fulfill our Mission to help our Members help Patients by driving capital formation and fostering entrepreneurship, advocating for public policies that advance medical innovation, providing access to talent and education and offering a cost-saving array of critical commercial resources. For more information about BioNJ, please visit www.BioNJ.org.